Programming of Intestinal Epithelial Differentiation by IL-33 Derived from Pericryptal Fibroblasts in Response to Systemic Infection

Cell Reports

Volumn 15, Issue 8, 2016, Pages 1743-1756

  Mahapatro, Mousumi ^a   Foersch, Sebastian ^a   Hefele, Manuela ^a   He, Gui Wei ^a   Giner Ventura, Elisa ^b   Mchedlidze, Tamar ^a   Kindermann, Markus ^a   Vetrano, Stefania ^c   Danese, Silvio ^c   Günther, Claudia ^a   Neurath, Markus F ^a   Wirtz, Stefan ^a   Becker, Christoph ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 33; INTERLEUKIN RECEPTOR; NOTCH RECEPTOR; PROTEIN ST2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; IL1RL1 PROTEIN, MOUSE; INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CELL FATE; CELL ISOLATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; GOBLET CELL; HISTOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTESTINAL STEM CELL; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PANETH CELL; PERICRYPTAL FIBROBLAST; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SMALL INTESTINE; ANIMAL; ANIMAL SALMONELLOSIS; ANTIBODY SPECIFICITY; C57BL MOUSE; CELL LINEAGE; CELL PROLIFERATION; EPITHELIUM CELL; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; INTERLEUKIN-1 RECEPTOR-LIKE 1 PROTEIN; INTERLEUKIN-33; INTESTINAL MUCOSA; INTESTINE, SMALL; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN SPECIFICITY; RECEPTORS, NOTCH; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SIGNAL TRANSDUCTION;

EID: 84966659702     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.04.049     Document Type: Article

References (61)

1. Alves-Filho J.C., Sônego F., Souto F.O., Freitas A., Verri W.A., Auxiliadora-Martins M., Basile-Filho A., McKenzie A.N., Xu D., Cunha F.Q., Liew F.Y. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat. Med. 2010, 16:708-712.
2. Bamias G., Corridoni D., Pizarro T.T., Cominelli F. New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation. Cytokine 2012, 59:451-459.
3. Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., Haegebarth A., Korving J., Begthel H., Peters P.J., Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
4. Barthel M., Hapfelmeier S., Quintanilla-Martínez L., Kremer M., Rohde M., Hogardt M., Pfeffer K., Rüssmann H., Hardt W.D. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 2003, 71:2839-2858.
5. Beltrán C.J., Núñez L.E., Díaz-Jiménez D., Farfan N., Candia E., Heine C., López F., González M.J., Quera R., Hermoso M.A. Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 2010, 16:1097-1107.
6. Espinassous Q., Garcia-de-Paco E., Garcia-Verdugo I., Synguelakis M., von Aulock S., Sallenave J.M., McKenzie A.N., Kanellopoulos J. IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex. J. Immunol. 2009, 183:1446-1455.
7. Fre S., Huyghe M., Mourikis P., Robine S., Louvard D., Artavanis-Tsakonas S. Notch signals control the fate of immature progenitor cells in the intestine. Nature 2005, 435:964-968.
8. Gazit R., Krizhanovsky V., Ben-Arie N. Math1 controls cerebellar granule cell differentiation by regulating multiple components of the Notch signaling pathway. Development 2004, 131:903-913.
9. Gracz A.D., Magness S.T. Defining hierarchies of stemness in the intestine: evidence from biomarkers and regulatory pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 2014, 307:G260-G273.
10. Grassl G.A., Valdez Y., Bergstrom K.S., Vallance B.A., Finlay B.B. Chronic enteric salmonella infection in mice leads to severe and persistent intestinal fibrosis. Gastroenterology 2008, 134:768-780.
11. Guabiraba R., Besnard A.G., Menezes G.B., Secher T., Jabir M.S., Amaral S.S., Braun H., Lima-Junior R.C., Ribeiro R.A., Cunha F.Q., et al. IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice. Mucosal Immunol. 2014, 7:1079-1093.
12. Haraldsen G., Balogh J., Pollheimer J., Sponheim J., Küchler A.M. Interleukin-33 - cytokine of dual function or novel alarmin?. Trends Immunol. 2009, 30:227-233.
13. Humphreys N.E., Xu D., Hepworth M.R., Liew F.Y., Grencis R.K. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J. Immunol. 2008, 180:2443-2449.
14. Imaeda H., Andoh A., Aomatsu T., Uchiyama K., Bamba S., Tsujikawa T., Naito Y., Fujiyama Y. Interleukin-33 suppresses Notch ligand expression and prevents goblet cell depletion in dextran sulfate sodium-induced colitis. Int. J. Mol. Med. 2011, 28:573-578.
15. Jensen J., Pedersen E.E., Galante P., Hald J., Heller R.S., Ishibashi M., Kageyama R., Guillemot F., Serup P., Madsen O.D. Control of endodermal endocrine development by Hes-1. Nat. Genet. 2000, 24:36-44.
16. Jobson T.M., Billington C.K., Hall I.P. Regulation of proliferation of human colonic subepithelial myofibroblasts by mediators important in intestinal inflammation. J. Clin. Invest. 1998, 101:2650-2657.
17. Jung P., Sato T., Merlos-Suárez A., Barriga F.M., Iglesias M., Rossell D., Auer H., Gallardo M., Blasco M.A., Sancho E., et al. Isolation and in vitro expansion of human colonic stem cells. Nat. Med. 2011, 17:1225-1227.
18. Kobori A., Yagi Y., Imaeda H., Ban H., Bamba S., Tsujikawa T., Saito Y., Fujiyama Y., Andoh A. Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J. Gastroenterol. 2010, 45:999-1007.
19. Koyasu S., Moro K. Th2-type innate immune responses mediated by natural helper cells. Ann. N Y Acad. Sci. 2013, 1283:43-49.
20. Lawrance I.C., Maxwell L., Doe W. Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease. Inflamm. Bowel Dis. 2001, 7:226-236.
21. Liévin-Le Moal V., Servin A.L. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin. Microbiol. Rev. 2006, 19:315-337.
22. Liew F.Y., Pitman N.I., McInnes I.B. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 2010, 10:103-110.
23. Liu Q., Turnquist H.R. Implications for Interleukin-33 in solid organ transplantation. Cytokine 2013, 62:183-194.
24. Loomis W.P., Johnson M.L., Brasfield A., Blanc M.P., Yi J., Miller S.I., Cookson B.T., Hajjar A.M. Temporal and anatomical host resistance to chronic Salmonella infection is quantitatively dictated by Nramp1 and influenced by host genetic background. PLoS ONE 2014, 9:e111763.
25. Lopetuso L.R., Chowdhry S., Pizarro T.T. Opposing functions of classic and novel IL-1 family members in gut health and disease. Front. Immunol. 2013, 4:181.
26. Martin M.U. Special aspects of interleukin-33 and the IL-33 receptor complex. Semin. Immunol. 2013, 25:449-457.
27. Martini E., Wittkopf N., Günther C., Leppkes M., Okada H., Watson A.J., Podstawa E., Backert I., Amann K., Neurath M.F., Becker C. Loss of survivin in intestinal epithelial progenitor cells leads to mitotic catastrophe and breakdown of gut immune homeostasis. Cell Rep. 2016, 14:1062-1073.
28. McHedlidze T., Waldner M., Zopf S., Walker J., Rankin A.L., Schuchmann M., Voehringer D., McKenzie A.N., Neurath M.F., Pflanz S., Wirtz S. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity 2013, 39:357-371.
29. Moro K., Yamada T., Tanabe M., Takeuchi T., Ikawa T., Kawamoto H., Furusawa J., Ohtani M., Fujii H., Koyasu S. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010, 463:540-544.
30. Noah T.K., Shroyer N.F. Notch in the intestine: regulation of homeostasis and pathogenesis. Annu. Rev. Physiol. 2013, 75:263-288.
31. Obata Y., Takahashi D., Ebisawa M., Kakiguchi K., Yonemura S., Jinnohara T., Kanaya T., Fujimura Y., Ohmae M., Hase K., Ohno H. Epithelial cell-intrinsic Notch signaling plays an essential role in the maintenance of gut immune homeostasis. J. Immunol. 2012, 188:2427-2436.
32. Oboki K., Ohno T., Kajiwara N., Saito H., Nakae S. IL-33 and IL-33 receptors in host defense and diseases. Allergol. Int. 2010, 59:143-160.
33. Ouellette A.J. Paneth cell α-defensins in enteric innate immunity. Cell. Mol. Life Sci. 2011, 68:2215-2229.
34. Palmer G., Gabay C. Interleukin-33 biology with potential insights into human diseases. Nat. Rev. Rheumatol. 2011, 7:321-329.
35. Papadakis K.A., Targan S.R. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 2000, 51:289-298.
36. Pastorelli L., Garg R.R., Hoang S.B., Spina L., Mattioli B., Scarpa M., Fiocchi C., Vecchi M., Pizarro T.T. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proc. Natl. Acad. Sci. USA 2010, 107:8017-8022.
37. Pastorelli L., De Salvo C., Vecchi M., Pizarro T.T. The role of IL-33 in gut mucosal inflammation. Mediators Inflamm. 2013, 2013:608187.
38. Pellegrinet L., Rodilla V., Liu Z., Chen S., Koch U., Espinosa L., Kaestner K.H., Kopan R., Lewis J., Radtke F. Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells. Gastroenterology 2011, 140:1230-1240.e1, 7.
39. Polumuri S.K., Jayakar G.G., Shirey K.A., Roberts Z.J., Perkins D.J., Pitha P.M., Vogel S.N. Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists. J. Immunol. 2012, 189:50-60.
40. Riedel C.U., Casey P.G., Mulcahy H., O'Gara F., Gahan C.G., Hill C. Construction of p16Slux, a novel vector for improved bioluminescent labeling of gram-negative bacteria. Appl. Environ. Microbiol. 2007, 73:7092-7095.
41. Rostan O., Arshad M.I., Piquet-Pellorce C., Robert-Gangneux F., Gangneux J.P., Samson M. Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases. Infect. Immun. 2015, 83:1738-1748.
42. Sato T., Vries R.G., Snippert H.J., van de Wetering M., Barker N., Stange D.E., van Es J.H., Abo A., Kujala P., Peters P.J., Clevers H. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009, 459:262-265.
43. Sato T., van Es J.H., Snippert H.J., Stange D.E., Vries R.G., van den Born M., Barker N., Shroyer N.F., van de Wetering M., Clevers H. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 2011, 469:415-418.
44. Schiering C., Krausgruber T., Chomka A., Fröhlich A., Adelmann K., Wohlfert E.A., Pott J., Griseri T., Bollrath J., Hegazy A.N., et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 2014, 513:564-568.
45. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., Zurawski G., Moshrefi M., Qin J., Li X., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
46. Sedhom M.A., Pichery M., Murdoch J.R., Foligné B., Ortega N., Normand S., Mertz K., Sanmugalingam D., Brault L., Grandjean T., et al. Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice. Gut 2013, 62:1714-1723.
47. Seidelin J.B., Rogler G., Nielsen O.H. A role for interleukin-33 in T(H)2-polarized intestinal inflammation?. Mucosal Immunol. 2011, 4:496-502.
48. Shimizu H., Okamoto R., Ito G., Fujii S., Nakata T., Suzuki K., Murano T., Mizutani T., Tsuchiya K., Nakamura T., et al. Distinct expression patterns of Notch ligands, Dll1 and Dll4, in normal and inflamed mice intestine. PeerJ 2014, 2:e370.
49. Skarnes W.C., Rosen B., West A.P., Koutsourakis M., Bushell W., Iyer V., Mujica A.O., Thomas M., Harrow J., Cox T., et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature 2011, 474:337-342.
50. Sponheim J., Pollheimer J., Olsen T., Balogh J., Hammarström C., Loos T., Kasprzycka M., Sørensen D.R., Nilsen H.R., Küchler A.M., et al. Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am. J. Pathol. 2010, 177:2804-2815.
51. Sundlisaeter E., Edelmann R.J., Hol J., Sponheim J., Küchler A.M., Weiss M., Udalova I.A., Midwood K.S., Kasprzycka M., Haraldsen G. The alarmin IL-33 is a notch target in quiescent endothelial cells. Am. J. Pathol. 2012, 181:1099-1111.
52. Tian H., Biehs B., Chiu C., Siebel C.W., Wu Y., Costa M., de Sauvage F.J., Klein O.D. Opposing activities of Notch and Wnt signaling regulate intestinal stem cells and gut homeostasis. Cell Rep. 2015, 11:33-42.
53. Tsai Y.H., VanDussen K.L., Sawey E.T., Wade A.W., Kasper C., Rakshit S., Bhatt R.G., Stoeck A., Maillard I., Crawford H.C., et al. ADAM10 regulates Notch function in intestinal stem cells of mice. Gastroenterology 2014, 147:822-834.e13.
54. Turnquist H.R., Zhao Z., Rosborough B.R., Liu Q., Castellaneta A., Isse K., Wang Z., Lang M., Stolz D.B., Zheng X.X., et al. IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J. Immunol. 2011, 187:4598-4610.
55. VanDussen K.L., Carulli A.J., Keeley T.M., Patel S.R., Puthoff B.J., Magness S.T., Tran I.T., Maillard I., Siebel C., Kolterud Å., et al. Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells. Development 2012, 139:488-497.
56. Vereecke L., Beyaert R., van Loo G. Enterocyte death and intestinal barrier maintenance in homeostasis and disease. Trends Mol. Med. 2011, 17:584-593.
57. Vidal S., Tremblay M.L., Govoni G., Gauthier S., Sebastiani G., Malo D., Skamene E., Olivier M., Jothy S., Gros P. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J. Exp. Med. 1995, 182:655-666.
58. von Moltke J., Ji M., Liang H.E., Locksley R.M. Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. Nature 2016, 529:221-225.
59. Wong S.H., Walker J.A., Jolin H.E., Drynan L.F., Hams E., Camelo A., Barlow J.L., Neill D.R., Panova V., Koch U., et al. Transcription factor RORα is critical for nuocyte development. Nat. Immunol. 2012, 13:229-236.
60. Yang Q., Bermingham N.A., Finegold M.J., Zoghbi H.Y. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 2001, 294:2155-2158.
61. Yang Z., Sun R., Grinchuk V., Fernández-Blanco J.A., Notari L., Bohl J.A., McLean L.P., Ramalingam T.R., Wynn T.A., Urban J.F., et al. IL-33-induced alterations in murine intestinal function and cytokine responses are MyD88, STAT6, and IL-13 dependent. Am. J. Physiol. Gastrointest. Liver Physiol. 2013, 304:G381-G389.